ACLY and metabolic dysfunction-associated steatohepatitis: The interquartile range (IQR) in MASH patients, equal to 0.55, suggested that 50% of NASH patients enrolled had ACLY mRNA from 1.14 to 1.69-fold changes of healthy subjects (Fig. 7A).